SCHEMBL31375503

SCHEMBL31375503

Cc1ccc(-c2cnc(C(F)(F)F)nc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.42
AR P10275 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
LRRK2 Q5S007 2/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
MAPT P10636 2/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MCHR1 Q99705 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26635446 0.79 NPC1 (0.44) NPSR1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL5078717 0.78 RAB9A (0.54) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL16906666 0.77 AR (0.46) ARNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL254676 0.77 APLNR (0.39) ALDH1A1
SCHEMBL12441005 0.76 NPSR1 (0.46) NPSR1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL10000245 0.75 NPSR1 (0.48) NPSR1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL10000246 0.75 NPSR1 (0.48) NPSR1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL31375475 0.75 PDPK1 (0.36) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL16635089 0.73 HSP90AA1 (0.37) MAPTMCHR1TP53POLB
SCHEMBL2608309 0.73 NPC1 (0.60) NPSR1NPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119677733-A Bicyclic tetrahydrothiazepine derivatives 豪夫迈·罗氏有限公司 2025-03-21 CN disclosed